Ticker Details
Stoke Therapeutics, Inc.
IPO Date:	June 17, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.83B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.67 | 3.28%
Avg Daily Range (30 D):	$0.62 | 1.87%
Avg Daily Range (90 D):	$0.86 | 2.64%

Institutional Daily Volume
Avg Daily Volume:	.35M
Avg Daily Volume (30 D):	.38M
Avg Daily Volume (90 D):	.52M

Trade Size
Avg Trade Size (Sh.):	74
Avg Trade Size (Sh.) (30 D):	45
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	1,569
Avg Institutional Trade:	$2.22M
Avg Institutional Trade (30 D):	$2.64M
Avg Institutional Trade (90 D):	$3.37M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.15M
Avg Closing Trade (30 D):	$3.84M
Avg Closing Trade (90 D):	$4.01M
Avg Closing Volume:	102.34K

News

Jun 28, 2024 @ 4:01 PM A Closer Look at 5 Analyst Recommendations For Sto... Source: Benzinga Insights

May 6, 2024 @ 3:01 PM Analyst Expectations For Stoke Therapeutics's Futu... Source: Benzinga Insights

May 6, 2024 @ 12:05 PM Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, T... Source: Zacks Equity Research

Apr 29, 2024 @ 2:00 PM Earnings Preview: Axsome Therapeutics (AXSM) Q1 Ea... Source: Zacks Equity Research

Apr 25, 2024 @ 2:01 PM Earnings Preview: Stoke Therapeutics, Inc. (STOK) ... Source: Zacks Equity Research

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2.84	$-.79	$-1
Diluted EPS	$-2.81	$-.79	$-.97
Revenue	$32.08M	$6.23M	$1.4M
Gross Profit
Net Income / Loss	$-169.77M	$-50M	$-57.93M
Operating Income / Loss	$-185.25M	$-53.42M	$-61.44M
Cost of Revenue
Net Cash Flow	$-116.23M	$74.44M	$.83M
PE Ratio

Splits
Jun 06, 2019	10:99